StockWatch
·
Pharmaceuticals
Board Meeting28 Oct 2026, 09:01 pm

Aarti Pharmalabs Board Approves Q2 FY27 Unaudited Results; Appoints New CFO

AI Summary

Aarti Pharmalabs Ltd announced that its Board of Directors, in a meeting held on October 28, 2026, approved the unaudited financial results for the quarter and half-year ended September 30, 2026. The company also noted the resignation of its Chief Financial Officer (CFO), Shri. Piyush Lakhani, effective October 30, 2026, due to his pursuit of an external career opportunity. Concurrently, Smt. Vibha Thakkar has been appointed as the new CFO and Key Managerial Personnel, effective October 31, 2026. Smt. Thakkar brings over 18 years of experience in finance across various industries.

Key Highlights

  • Board approved unaudited financial results for Q2 FY27 and H1 FY27.
  • CFO Shri. Piyush Lakhani resigned to pursue other opportunities.
  • Smt. Vibha Thakkar appointed as new CFO effective October 31, 2026.
  • Smt. Thakkar has over 18 years of finance experience.
  • Financial results are available on the company website.